The proximal promoter region of the human vascular endothelial growth factor gene has a G-quadruplex structure that can be targeted by G-quadruplex–interactive agents
- 1 April 2008
- journal article
- Published by American Association for Cancer Research (AACR) in Molecular Cancer Therapeutics
- Vol. 7 (4) , 880-889
- https://doi.org/10.1158/1535-7163.mct-07-2119
Abstract
Previous studies on the functional analysis of the human vascular endothelial growth factor (VEGF) promoter using the full-length VEGF promoter reporter revealed that the proximal 36-bp region (−85 to −50 relative to transcription initiation site) is essential for basal or inducible VEGF promoter activity in several human cancer cells. This region consists of a polypurine (guanine) tract that contains four runs of at least three contiguous guanines separated by one or more bases, thus conforming to a general motif capable of forming an intramolecular G-quadruplex. Here, we show that the G-rich strand in this region is able to form an intramolecular propeller-type parallel-stranded G-quadruplex structure in vitro by using the electrophoretic mobility shift assay, dimethyl sulfate footprinting technique, the DNA polymerase stop assay, circular dichroism spectroscopy, and computer-aided molecular modeling. Two well-known G-quadruplex–interactive agents, TMPyP4 and Se2SAP, stabilize G-quadruplex structures formed by this sequence in the presence of a potassium ion, although Se2SAP is at least 10-fold more effective in binding to the G-quadruplex than TMPyP4. Between these two agents, Se2SAP better suppresses VEGF transcription in different cancer cell lines, including HEC1A and MDA-MB-231. Collectively, our results provide evidence that specific G-quadruplex structures can be formed in the VEGF promoter region, and that the transcription of this gene can be controlled by ligand-mediated G-quadruplex stabilization. Our results also provide further support for the idea that G-quadruplex structures may play structural roles in vivo and therefore might provide insight into novel methodologies for rational drug design. [Mol Cancer Ther 2008;7(4):880–9]Keywords
This publication has 44 references indexed in Scilit:
- Characterization of the G-quadruplexes in the duplex nuclease hypersensitive element of the PDGF-A promoter and modulation of PDGF-A promoter activity by TMPyP4Nucleic Acids Research, 2007
- Formation of Pseudosymmetrical G-Quadruplex and i-Motif Structures in the Proximal Promoter Region of the RET OncogeneJournal of the American Chemical Society, 2007
- Single-Molecule Conformational Analysis of G-Quadruplex Formation in the Promoter DNA Duplex of the Proto-Oncogene C-KitJournal of the American Chemical Society, 2007
- G-quadruplexes in promoters throughout the human genomeNucleic Acids Research, 2006
- NMR solution structure of the major G-quadruplex structure formed in the human BCL2 promoter regionNucleic Acids Research, 2006
- Deconvoluting the Structural and Drug-Recognition Complexity of the G-Quadruplex-Forming Region Upstream of the bcl-2 P1 PromoterJournal of the American Chemical Society, 2006
- G-quadruplex formation within the promoter of the KRAS proto-oncogene and its effect on transcriptionNucleic Acids Research, 2006
- Molecular diagnosis of tumor angiogenesis and anti-angiogenic cancer therapyInternational Journal of Clinical Oncology, 2003
- Antiangiogenic agents targeting vascular endothelial growth factor and its receptors in clinical developmentExpert Opinion on Investigational Drugs, 2002
- Tumor Angiogenesis: Therapeutic ImplicationsNew England Journal of Medicine, 1971